⸺ Synova Research
KLOW
Research blend combining KPV, BPC-157, TB-500 and GHK-Cu in a single 80mg vial — studied for inflammation, tissue repair and skin pathways.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Peptides sold in lyophilized form
- • Strictly for laboratory research
⸺ Overview
About KLOW
KLOW is a combined research blend pairing KPV with BPC-157, TB-500 and GHK-Cu in a single vial. Researchers use it to investigate overlapping pathways across anti-inflammatory signalling, soft-tissue repair and skin biology in one preparation.
⸺ Mechanism of Action
How it works
KPV modulates NF-κB and inflammatory cytokine output. BPC-157 influences growth-factor and nitric-oxide signalling for tissue protection. TB-500 regulates actin dynamics and cell migration. GHK-Cu drives copper-dependent collagen and elastin gene expression. Combined, the four peptides target complementary repair and inflammation pathways in preclinical models.
⸺ Research
Areas of study
Inflammation models
Preclinical work with KPV describes reduced inflammatory markers across gut, skin and systemic models.
Soft-tissue repair
Animal models with BPC-157 and TB-500 show improved tendon, ligament and muscle repair with reduced inflammation at injury sites.
Skin and collagen biology
GHK-Cu research shows enhanced collagen and elastin synthesis and improved dermal architecture in preclinical models.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- Blend — KPV / BPC-157 / TB-500 / GHK-Cu
- Intended use
- Research use only. Multi-peptide blend.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Maintain sterile technique.
You might also research
View all →
R3TA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
T1RZ
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.